JP4942307B2 - Animal mineral supplements - Google Patents

Animal mineral supplements Download PDF

Info

Publication number
JP4942307B2
JP4942307B2 JP2005112150A JP2005112150A JP4942307B2 JP 4942307 B2 JP4942307 B2 JP 4942307B2 JP 2005112150 A JP2005112150 A JP 2005112150A JP 2005112150 A JP2005112150 A JP 2005112150A JP 4942307 B2 JP4942307 B2 JP 4942307B2
Authority
JP
Japan
Prior art keywords
formula
mineral supplement
sodium
solid solution
mol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2005112150A
Other languages
Japanese (ja)
Other versions
JP2006290780A (en
Inventor
宮田茂男
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sea Water Chemical Institute Inc
Original Assignee
Sea Water Chemical Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sea Water Chemical Institute Inc filed Critical Sea Water Chemical Institute Inc
Priority to JP2005112150A priority Critical patent/JP4942307B2/en
Publication of JP2006290780A publication Critical patent/JP2006290780A/en
Application granted granted Critical
Publication of JP4942307B2 publication Critical patent/JP4942307B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

本発明は、動物用ミネラル補給剤に関する。更に詳しくは、微量ミネラル―鉄、亜鉛、銅およびマンガン―および超微量ミネラル―クロム、コバルト、ニッケル―を固溶した水酸化マグネシウム系固溶体を主成分とする動物用ミネラル補給剤に関する。   The present invention relates to an animal mineral supplement. More specifically, the present invention relates to an animal mineral supplement mainly composed of a magnesium hydroxide-based solid solution in which trace minerals-iron, zinc, copper and manganese- and ultratrace minerals-chromium, cobalt, nickel- are dissolved.

近年の著しい無機生物化学の進歩により、微量金属が動物の健康と疾病に深く係わっていることが明らかになってきた。動物に必須の微量金属とは、1日の摂取必要量が約1〜10mgのFe,Zn,CuおよびMnと、それよりも必要摂取量が約1ケタ少ない(超微量金属―Se(セレン),I(ヨウド),Mo(モリブデン),Cr(クロム),Co(コバルト)―等である。これ等必須の微量ミネラルをそれぞれの必要量食物から摂取するためには、数多くの食材をバランス良く摂る必要がある。しかし、現在の一般人の生活は多忙になり、上記条件を満足させられない人が多くなっている。そのため、栄養補助食品として、種々のミネラル剤が販売されている。例えば、酸化亜鉛、酸化第2銅、クエン酸鉄ナトリウム、グルコン酸第1鉄、炭酸マンガン、亜鉛、マンガン、セレン、銅、クロムおよびモリブデンの酵母等である。以上の如き各種ミネラル成分を炭酸カルシウム、炭酸マグネシウム、ドロマイト等の比較的多量必要とされるミネラルと一緒にし、微結晶セルロース等の賦形剤と共に混合し、錠剤に成型し、1日当たり2〜4g服用させることが一般的に行われている。   Recent advances in inorganic biochemistry have revealed that trace metals are deeply involved in animal health and disease. The essential trace metals for animals are Fe, Zn, Cu and Mn with a daily intake requirement of about 1 to 10 mg, and the required intake is about 1 digit less than that (ultra-trace metal-Se (selenium)) , I (iodine), Mo (molybdenum), Cr (chromium), Co (cobalt)-etc. In order to ingest these essential trace minerals from their respective required foods, a large number of ingredients must be balanced. However, the current life of ordinary people has become busy, and many people are unable to satisfy the above conditions, so various mineral preparations are sold as dietary supplements. Zinc oxide, cupric oxide, sodium iron citrate, ferrous gluconate, manganese carbonate, zinc, manganese, selenium, copper, chromium and molybdenum yeast, etc. Various minerals as described above It is common to mix a portion with minerals such as calcium carbonate, magnesium carbonate, and dolomite that are needed in a relatively large amount, mix with excipients such as microcrystalline cellulose, mold into tablets, and take 2-4 g per day Has been done.

微量金属は、比較的多量必要とされる必須ミネラル−CaとかMg−が、吸収性が良好であるのに対し、一般的に吸収性が悪い欠点がある。微量〜超微量ミネラルは、個々に1日に必要とされる最適量があり、その量より少ないと種々の欠乏症を発生すると共に、逆に多すぎると種々の過剰症を発生させる。そのため、1錠当たり約400mg〜3g中に約10種類近いミネラルを正確に混合、均質化する必要があり、その生産は煩雑である。且つ精密性が要求され、コストが掛かる問題がある。   Trace metals have a drawback that they are generally poor in absorptivity, while essential minerals -Ca and Mg-, which are required in relatively large amounts, have good absorptivity. There is an optimum amount of trace amount to ultra-trace amount mineral required individually for one day, and if it is less than that amount, various deficiencies are generated, and conversely, if it is too much, various excess diseases are generated. Therefore, it is necessary to accurately mix and homogenize about 10 kinds of minerals in about 400 mg to 3 g per tablet, and the production is complicated. In addition, there is a problem that precision is required and cost is increased.

本発明は、(a)下記式(1)   The present invention provides (a) the following formula (1)

Figure 0004942307
(但し、式中、M 1 はCr3+,Co ,N2+の少なくとも1種以上を示し、x〜x4,x,yおよびzはそれぞれ次の範囲にある、0<x<0.1、好ましくは0.006≦x≦0.04,0<x2<0.2、好ましくは0.007≦x2≦0.05,0<x3<0.02、好ましくは0.001≦x3≦0.009,0<x4<0.04、好ましくは0.002≦x4≦0.02,0<x<0.15、好ましくは0.01≦x≦0.1、特に好ましくは0.02≦x≦0.08,x+x2+x3+x4,0≦y≦0.004、好ましくは0.0002≦y≦0.004,0≦z<0.05)で表される水酸化マグネシウム系固溶体、または該固溶体に(b)セレン、ヨウ素、モリブデン含有化合の少なくとも1種以上を吸着または均一混合した物を有効成分として含有する動物用ミネラル補給剤を提供する。
Figure 0004942307
(Wherein, M 1 is Cr 3+, Co 2 +, indicates at least one or more kinds of N i 2+, x 1 ~x 4 , x, y and z are each in the following range, 0 <x 1 <0.1, preferably 0.006 ≦ x 1 ≦ 0.04, 0 <x 2 <0.2, preferably 0.007 ≦ x 2 ≦ 0.05, 0 <x 3 <0.02, preferably 0.001 ≦ x 3 ≦ 0.009, 0 <x 4 <0.04, preferably 0.002 ≦ x 4 ≦ 0.02, 0 <x <0.15, preferably 0.01 ≦ x ≦ 0.1, particularly preferably 0.02 ≦ x ≦ 0.08, x 1 + x 2 + x 3 + x 4 = x , 0 ≦ y ≦ 0.004 , preferably 0.0002 ≦ y ≦ 0.004 , 0 ≦ z <0.05) or a magnesium hydroxide-based solid solution represented by z <0.05) or (b) a compound containing less selenium, iodine and molybdenum. It provides an animal for mineral supplement containing those also adsorbed or uniformly mixing one or more as an active ingredient.

本発明によれば、一般に吸収性が悪い微量ミネラル及び超微量ミネラルの吸収性を改善できると共に、便通が大幅に良くなる。さらに、必須とされる殆どの微量、超微量ミネラルが、水酸化マグネシウム結晶中に、それぞれの必要最適量分子レベルで分散させることが出来、煩雑な計量と困難な混合を含む製剤工程を省略または簡素化できる。   According to the present invention, it is possible to improve the absorbability of trace minerals and ultratrace minerals that are generally poorly absorbable, and greatly improve the bowel movement. Furthermore, most of the essential trace and ultra trace minerals can be dispersed in the magnesium hydroxide crystals at the respective required optimum amounts at the molecular level, omitting the formulation process including complicated weighing and difficult mixing or It can be simplified.

本発明の式(1)で表されるミネラル補給剤は、水酸化マグネシウム結晶中に必須ミネラルが原子状で分散した、いわゆる固溶体であり、X線回析パターンは水酸化マグネシウムだけを示す物質である。微量および超微量ミネラルは、それぞれ1日当たりの必要量があり、各ミネラルが適正の範囲で固溶していることが好ましい。したがって、x〜x4,xおよびyの好ましい範囲は0.006≦x≦0.04,0.007≦x≦0.05,0.001≦x3≦0.009,0.002≦x≦0.02,0.01≦x≦0.1,0.90≦1−x−y−z≦0.99,0.0002≦y≦0.004である。また、式(1)の固溶体に吸着または均一混合する(b成分)セレン、ヨウ素、モリブデンの合計モル量の好ましい範囲は、式(1)の固溶体1モルに対し、0.0002〜0.004モルである。 The mineral supplement represented by the formula (1) of the present invention is a so-called solid solution in which essential minerals are dispersed atomically in magnesium hydroxide crystals, and the X-ray diffraction pattern is a substance that shows only magnesium hydroxide. is there. The trace amount and the ultra-trace amount mineral each have a necessary amount per day, and it is preferable that each mineral is dissolved in an appropriate range. Thus, x 1 ~x 4, a preferred range of x and y is 0.006 ≦ x 1 ≦ 0.04,0.007 ≦ x 2 ≦ 0.05,0.001 ≦ x 3 ≦ 0.009,0. 002 ≦ x 4 ≦ 0.02, 0.01 ≦ x ≦ 0.1, 0.90 ≦ 1-xyz ≦ 0.99, 0.0002 ≦ y ≦ 0.004. Moreover, the preferable range of the total molar amount of selenium, iodine, and molybdenum adsorbed or uniformly mixed in the solid solution of the formula (1) is 0.0002 to 0.004 with respect to 1 mol of the solid solution of the formula (1). Is a mole.

本発明で用いるセレン、ヨウ素およびモリブデン含有化合物としては、例えば亜セレン酸ナトリウム、亜セレン酸ナトリウム、セレン酵母、ヨウ化カリウム、ヨウ化ナトリウム、モリブデン酸ナトリウム、モリブデン酸アンモニウム等を挙げることができる。   Examples of the selenium, iodine and molybdenum-containing compound used in the present invention include sodium selenite, sodium selenite, selenium yeast, potassium iodide, sodium iodide, sodium molybdate, ammonium molybdate and the like.

本発明ミネラル補給剤の式(1)の固溶体(a成分)の好ましい代表的組成は、次の如き物である。
Mg0.97Fe0.011Zn0.014Cu0.002Mn0.004Cr0.00007(OH)
Mg0.94Fe0.02Zn 0.026 Cu0.0046Mn0.008Cr0.0001(OH)
本発明の好ましい組成としては、上記成分にセレン、ヨウ素およびモリブデンの全てを式(1)の固溶体1モルに対し、0.01モル以下、好ましくは、0.0002モル〜0.004モルの、換言すると約1mg以下の(b)成分を加えたものである。
A preferable typical composition of the solid solution (component a) of the formula (1) of the mineral supplement of the present invention is as follows.
Mg 0.97 Fe 0.011 Zn 0.014 Cu 0.002 Mn 0.004 Cr 0.00007 (OH) 2
Mg 0.94 Fe 0.02 Zn 0.026 Cu 0.0046 Mn 0.008 Cr 0.0001 (OH) 2
As a preferred composition of the present invention, all of selenium, iodine and molybdenum in the above components are 0.01 mol or less, preferably 0.0002 mol to 0.004 mol, relative to 1 mol of the solid solution of the formula (1). In other words, about 1 mg or less of component (b) is added.

本発明で用いる式(1)の水酸化マグネシウム系固溶体の製造は、目的のモル比に調合された各ミネラルの塩化物、硝酸塩、硫酸塩等の水溶液と、これとほぼ当量以上の水酸化ナトリウム等のアルカリ水溶液とを用い、共沈させる方法により実施できる。共沈反応後、ろ過、水洗、乾燥、粉砕等の工程を適宜選択して製造出来る。   The production of the magnesium hydroxide solid solution of the formula (1) used in the present invention comprises an aqueous solution of chlorides, nitrates, sulfates and the like of each mineral prepared at a target molar ratio, and sodium hydroxide equivalent to or more than this. It can implement by the method of coprecipitation using alkaline aqueous solution, such as. After the coprecipitation reaction, it can be produced by appropriately selecting steps such as filtration, washing with water, drying, and pulverization.

(b)成分の好ましい添加方法は、水洗後の式(1)の固溶体スラリーに添加、吸着後、スプレードライ、凍結乾燥等の乾燥方法を適用することである。この方法により、(b)成分を(a)成分に均一に吸着または混合することが出来る。特に、スプレードライが好ましく、この方法で流動性の粉体が得られ、そのまま錠剤に成型可能である。   A preferred method for adding the component (b) is to apply a drying method such as spray drying or freeze drying after addition and adsorption to the solid solution slurry of the formula (1) after washing with water. By this method, the component (b) can be uniformly adsorbed or mixed with the component (a). In particular, spray drying is preferable, and fluid powder can be obtained by this method and can be directly molded into a tablet.

本発明のミネラル補給剤は、水酸化マグネシウム系が主成分であるため、便通が改善される付加価値がある。   Since the mineral supplement of the present invention is mainly composed of magnesium hydroxide, it has the added value of improving bowel movement.

本発明のミネラル補給剤は、(a)(b)成分以外に、カルシウムを更に補給するために、炭酸カルシウム、クエン酸カルシウム、リンゴ酸カルシウム、カルシウムのクエン酸とリンゴ酸の複塩等のカルシウム化合物を混合使用することも出来る。これ等カルシウム化合物の添加量は、(a)成分の重量に基づき、10〜300%、好ましくは50〜200%である。   In addition to the components (a) and (b), the mineral supplement of the present invention is calcium carbonate, calcium citrate, calcium malate, calcium citric acid and malic acid double salt, etc. in order to further supplement calcium. A mixture of compounds can also be used. The amount of these calcium compounds added is 10 to 300%, preferably 50 to 200%, based on the weight of component (a).

以下、実施例に基づいて本発明をより詳細に説明する。   Hereinafter, the present invention will be described in more detail based on examples.

塩化マグネシウム、硫酸第一鉄、塩化亜鉛、硝酸第二銅、硝酸マンガン(II)および三塩化クロムの混合水溶液(Mg=1.944モル/リットル,Fe2+=0.019モル/リットル,Zn=0.024モル/リットル,Cu2+=0.0042モル/リットル,Mn2+=0.0074モル/リットル,Cr3+=0.0002モル/リットル)と4モル/リットルの水酸化ナトリウム水溶液をそれぞれ約100ml/分の流速で計量ポンプにより容量2リットルのオーバーフロー付き反応槽(予め約500ccの水を入れておく)に供給し、pHを水酸化ナトリウムの流量を調節して10.0〜10.4(温度:30〜31℃)に保って共沈反応させた。得られたスラリーをろ過、水洗後、水に再分散させ、スプレードライヤーを用い、入口温度約200℃、出口温度約80℃で乾燥した。この粉末は、流動性が良く、直接打錠が可能であった。この乾燥粉末のX線回析は水酸化マグネシウムのみの回析パターンを示した。したがって、各ミネラルが水酸化マグネシウム結晶に固溶している。乾燥物を塩酸に溶解後、1CPで元素分析を行い、組成を調べた結果は次の通りであった。Mg0.9726Fe 0.0095 Zn0.012Cu0.0021Mn0.0037Cr0.0001(OH)。この粉末1g当たり各ミネラルの含有量を重量で示すとMg=392mg(200〜700mg),Fe=9mg(8〜12mg),Zn=13mg(12〜18mg),Cu=2.3mg(2.2〜2.8mg),Mn=3.4mg(3〜5mg),Cr=0.05mg(0.06〜0.1mg)である。カッコ内は、成人1日当たり必要な摂取量を示す。 Mixed aqueous solution of magnesium chloride, ferrous sulfate, zinc chloride, cupric nitrate, manganese (II) nitrate and chromium trichloride (Mg = 1.944 mol / liter, Fe 2+ = 0.019 mol / liter, Zn = 0.024 mol / liter, Cu 2+ = 0.0042 mol / liter, Mn 2+ = 0.0074 mol / liter, Cr 3+ = 0.0002 mol / liter) and 4 mol / liter sodium hydroxide aqueous solution respectively. Supply to a reaction tank with overflow of 2 liters by a metering pump at a flow rate of 100 ml / min (previously put about 500 cc of water), and adjust pH of sodium hydroxide to 10.0 to 10.4. (Temperature: 30 to 31 ° C.) was used for coprecipitation reaction. The obtained slurry was filtered, washed with water, redispersed in water, and dried using a spray dryer at an inlet temperature of about 200 ° C. and an outlet temperature of about 80 ° C. This powder had good fluidity and could be directly compressed. X-ray diffraction of this dry powder showed a diffraction pattern of magnesium hydroxide only. Therefore, each mineral is dissolved in the magnesium hydroxide crystal. After the dried product was dissolved in hydrochloric acid, elemental analysis was performed with 1CP, and the composition was examined. The results were as follows. Mg 0.9726 Fe 0.0095 Zn 0.012 Cu 0.0021 Mn 0.0037 Cr 0.0001 (OH) 2 . When the content of each mineral per 1 g of this powder is expressed by weight, Mg = 392 mg (200 to 700 mg), Fe = 9 mg (8 to 12 mg), Zn = 13 mg (12 to 18 mg), Cu = 2.3 mg (2.2 ˜2.8 mg), Mn = 3.4 mg (3-5 mg), Cr = 0.05 mg (0.06-0.1 mg). The parentheses indicate the daily intake required for adults.

実施例1において、ミネラル混合水溶液を以下に示す溶液;塩化マグネシウム、硫酸第一鉄、硝酸亜鉛、硫酸第二銅、塩化マンガン(II)、三塩化クロムおよび硝酸第一コバルトの混合水溶液(Mg2+=1.84モル/リットル,Fe2+=0.054モル/リットル,Zn=0.068モル/リットル,Cu2+=0.011モル/リットル,Mn2+=0.02モル/リットル,Cr3+=0.0003モル/リットル,Co2+=0.0003モル/リットル)に変更する以外は実施例1と同様に行った。乾燥品のX線回析パターンは水酸化マグネシウムのみであった。化学組成は次の通りであった。Mg0.922Fe0.0267Zn0.0342Cu0.0058Mn0.0109Cr0.0001Co0.0001(OH)。この粉末1g当たり各ミネラルの含量はMg=360mg,Fe=24mg,Zn=36mg,Cu=6mg,Mn=10mg,Cr=0.05mg,Co=0.05mgである。この量は、成人でほぼ2日分に必要なミネラル量に相当する。 In Example 1, the following mineral mixed aqueous solution: Magnesium chloride, ferrous sulfate, zinc nitrate, cupric sulfate, manganese (II) chloride, chromium trichloride and cobaltous nitrate mixed aqueous solution (Mg 2+ = 1.84 mol / liter, Fe 2+ = 0.054 mol / liter, Zn = 0.068 mol / liter, Cu 2+ = 0.011 mol / liter, Mn 2+ = 0.02 mol / liter, Cr 3+ = 0.0003 mol / liter, Co 2+ = 0.0003 mol / liter). The X-ray diffraction pattern of the dried product was only magnesium hydroxide. The chemical composition was as follows: Mg 0.922 Fe 0.0267 Zn 0.0342 Cu 0.0058 Mn 0.0109 Cr 0.0001 Co 0.0001 (OH) 2. The content of each mineral per 1 g of this powder is Mg = 360 mg, Fe = 24 mg, Zn = 36 mg, Cu = 6 mg, Mn = 10 mg, Cr = 0.05 mg, Co = 0.05 mg. This amount corresponds to the amount of mineral required for approximately two days in an adult.

実施例1で得られた乾燥前のケーキをホモミキサーで水に均一に分散し、水酸化マグネシウム固溶体濃度約200g/リットルのスラリーを10リットル作成した。このスラリーに、セレン酸ナトリウム(NaSeO)を392mg、ヨウ化カリウムを394mg、モリブデン酸(KMoO)50mgを予め500mlの水に溶解した液を攪拌下に加え、約20分間攪拌した。このスラリーを、スプレードライヤーを用い、入口温度200℃、出口温度80℃で乾燥した。乾燥物の分析の結果、実施例1に示すミネラルの種類と量は実質的に変わらず、それ以外にSe=0.07mg,ヨード(I)=0.15mg,Mo=0.01mgが含有されていた。 The cake before drying obtained in Example 1 was uniformly dispersed in water with a homomixer to prepare 10 liters of a slurry having a magnesium hydroxide solid solution concentration of about 200 g / liter. A solution prepared by dissolving 392 mg of sodium selenate (NaSeO 4 ), 394 mg of potassium iodide, and 50 mg of molybdic acid (K 2 MoO 4 ) in 500 ml of water in advance was added to this slurry with stirring, and the mixture was stirred for about 20 minutes. This slurry was dried using a spray dryer at an inlet temperature of 200 ° C. and an outlet temperature of 80 ° C. As a result of the analysis of the dried product, the kind and amount of the mineral shown in Example 1 are not substantially changed, and in addition, Se = 0.07 mg, iodine (I) = 0.15 mg, and Mo = 0.01 mg are contained. It was.

実施例3において、実施例1で得られた水酸化マグネシウム固溶体の代わりに、実施例2で得られた水酸化マグネシウム固溶体スラリーを用い、且つセレン、ヨード、モリブデンと共にBET比表面積2.6m/gの微粒子沈降炭酸カルシウムを1,400g添加し、十分に攪拌し、均一化後、実施例3と同様にスプレードライした。乾燥物は流動性が良く、そのまま錠剤に成型出来る。乾燥物の1g当たりのミネラル含量はCa=410mg,Mg=210mg,Fe=14mg,Zn=21mg,Cu=3mg,Mn=6mg,Cr=0.03mg,Co=0.03mg,Se=0.04mg,ヨード(I)=0.09mg,Mo=0.006mgであった。 In Example 3, the magnesium hydroxide solid solution slurry obtained in Example 2 was used in place of the magnesium hydroxide solid solution obtained in Example 1, and a BET specific surface area of 2.6 m 2 / s together with selenium, iodine and molybdenum. After adding 1,400 g of g of particulate precipitated calcium carbonate, stirring sufficiently, and homogenizing, spray drying was performed in the same manner as in Example 3. The dried product has good fluidity and can be formed into a tablet as it is. The mineral content per gram of the dried product is Ca = 410 mg, Mg = 210 mg, Fe = 14 mg, Zn = 21 mg, Cu = 3 mg, Mn = 6 mg, Cr = 0.03 mg, Co = 0.03 mg, Se = 0.04 mg. , Iodine (I) = 0.09 mg, Mo = 0.006 mg.

および[比較例1〜4]
[酸に対する溶解性試験]動物による各ミネラルの吸収性は、胃酸による溶解性に依存すると考えられる。理想的な胃内pHが3〜5であるため、pH4におけるミネラルの溶解性を、pHスタットを用いて評価した。pHスタット(東亜電波製)を用い、人間の体温と同じ37℃に保った100mlの水に試料0.1gを添加し、pHを4に維持するために消費される0.1モル/リットル(ほぼ胃酸の濃度に相当)の塩酸量(ml)を経時的に測定した。試料は実施例1および2で得られた水酸化マグネシウム系固溶体[実施例5および6]、酸化亜鉛(試薬一級)[比較例1]、酸化第二銅(試薬一級)[比較例2]、炭酸マンガン(試薬一級)[比較例3]、水酸化二鉄[比較例4]をそれぞれ用いた。評価結果を図1に示す。図1で、塩酸の消費量は試料の溶解量に対応するため、塩酸の消費量が短時間で多く消費されるほど、試料の溶解性が高いことを意味する。
And [Comparative Examples 1 to 4]
[Acid Solubility Test] The absorbability of each mineral by an animal is considered to depend on the solubility by gastric acid. Since the ideal gastric pH is 3-5, the solubility of minerals at pH 4 was evaluated using a pH stat. Using a pH stat (manufactured by Toa Denpa), 0.1 mol / liter (0.1 mol / l) consumed to maintain pH at 4 by adding 0.1 g of sample to 100 ml of water kept at 37 ° C., which is the same as human body temperature. The amount (ml) of hydrochloric acid (approximately equivalent to the concentration of gastric acid) was measured over time. Samples were magnesium hydroxide solid solutions obtained in Examples 1 and 2 [Examples 5 and 6], zinc oxide (first grade reagent) [Comparative Example 1], cupric oxide (first grade reagent) [Comparative Example 2], Manganese carbonate (first grade reagent) [Comparative Example 3] and diiron hydroxide [Comparative Example 4] were used, respectively. The evaluation results are shown in FIG. In FIG. 1, since the consumption of hydrochloric acid corresponds to the dissolution of the sample, it means that the more the consumption of hydrochloric acid is consumed in a short time, the higher the solubility of the sample.

図1から明らかな如く、本発明ミネラル補給剤はpH4でも良く溶解する。しかし、従来のミネラル補給剤としてよく使用されている酸化亜鉛は、少し溶解するが、酸化第二銅とか炭酸マンガンは殆ど溶解しない。   As is apparent from FIG. 1, the mineral supplement of the present invention dissolves well even at pH 4. However, zinc oxide, which is often used as a conventional mineral supplement, dissolves a little, but cupric oxide or manganese carbonate hardly dissolves.

実施例1で得られた本発明ミネラル補給剤を毎日1g、3人の便秘性女性に一週間服用してもらった結果、2〜4日目から毎日便通が認められた。   As a result of taking 1 g of the mineral supplement of the present invention obtained in Example 1 every day for 3 weeks by three constipation women, bowel movements were observed every day from the 2nd to 4th days.

80〜90%白髪の男性(50代)に実施例1で得られた本発明ミネラル補給剤を毎日500mg、二ヶ月間服用してもらった結果、約一ヶ月後から黒い髪が増えていることが観察された。   As a result of having an 80-90% gray hair male (50s) take the mineral supplement of the present invention obtained in Example 1 every day for 500 months for 2 months, black hair has increased since about one month. Was observed.

pHスタットテスト結果を示す。設定pH=4,温度37℃縦軸:pHを4に維持するために消費された0.1m/lの塩酸量(ml)横軸:経過時間(分)The pH stat test results are shown. Set pH = 4, Temperature 37 ° C. Vertical axis: 0.1 m / l of hydrochloric acid consumed to maintain pH at 4 (ml) Horizontal axis: Elapsed time (min)

Claims (6)

下記式(1)
Figure 0004942307
(但し、式中、M はCr3+,Co ,N2+の少なくとも1種以上を示し、x,x2,x3,x4,x,yおよびzは次の条件を満足する、x+x2+x3+x4,0<x<0.1,0<x2<0.2,0<x3<0.02,0<x4<0.04,0<x<0.15,0≦y≦0.004,0≦z<0.05)で表される水酸化マグネシウム系固溶体を有効成分として含有する動物用ミネラル補給剤。
Following formula (1)
Figure 0004942307
(Wherein, M 1 is Cr 3+, Co 2 +, it indicates at least one or more kinds of N i 2+, x 1, x 2, x 3, x 4, x, y and z satisfy the following conditions to, x 1 + x 2 + x 3 + x 4 = x, 0 <x 1 <0.1,0 <x 2 <0.2,0 <x 3 <0.02,0 <x 4 <0.04,0 <X <0.15, 0 <= y <= 0.004 , 0 <= z <0.05) The mineral supplement for animals which contains the magnesium hydroxide type | system | group solid solution represented by an active ingredient as an active ingredient.
式(1)の固溶体1モルに、亜セレン酸ナトリウム、セレン酵母、ヨウ化カリウム、ヨウ化ナトリウム、モリブデン酸ナトリウム、モリブデン酸アンモニウムからなる群から選ばれたSe(セレン)、I(ヨウ素)およびMo(モリブデン)化合物の少なくとも1種以上の超微量ミネラルMを0.01モル以下の量で、吸着または均一混合させた請求項1記載の動物用ミネラル補給剤。 Se (selenium), I (iodine) selected from the group consisting of sodium selenite, selenium yeast, potassium iodide, sodium iodide, sodium molybdate, ammonium molybdate and 1 mol of the solid solution of formula (1) Mo (molybdenum) in small without even the amount of one or more ultra-trace minerals M 2 0.01 mol of the compound, veterinary mineral supplement of claim 1 which has been adsorbed or uniformly mixed. 式(1)のx,x2,x3,x4およびxがそれぞれ次の範囲、0.006≦x≦0.04,0.007≦x2≦0.05,0.001≦x3≦0.009,0.002≦x≦0.02,0.01≦x≦0.1,にあることを特徴とする請求項1記載の動物用ミネラル補給剤。 In formula (1), x 1 , x 2 , x 3 , x 4 and x are in the following ranges, 0.006 ≦ x ≦ 0.04, 0.007 ≦ x 2 ≦ 0.05, 0.001 ≦ x The animal mineral supplement according to claim 1, wherein 3 ≤ 0.009, 0.002 ≤ x 4 ≤ 0.02, 0.01 ≤ x ≤ 0.1. 式(1)において、xに対する,x2,x3,x4の割合がそれぞれ、 /x=0.35±0.1, 2 /x=0.44±0.1, 3 /x0.077±0.016, /x=0.136±0.027であることを特徴とする請求項1記載の動物用ミネラル補給剤。 In the formula (1), x 1 with respect to x, x 2, x 3, the ratio of x 4, respectively, x 1 / x = 0.35 ± 0.1, x 2 / x = 0.44 ± 0.1, x 3 / x = 0.077 ± 0.016 , veterinary mineral supplement according to claim 1, characterized in that the x 4 / x = 0.136 ± 0.027 . 式(1)の固溶体または請求項2の混合物に、炭酸カルシウム、クエン酸カルシウム、リンゴ酸カルシウムおよびクエン酸とリンゴ酸の複合カルシウム塩の中から選ばれた少なくとも1種以上を10〜300%混合させた請求項1又は2記載の動物用ミネラル補給剤。 10 to 300% of at least one selected from calcium carbonate, calcium citrate, calcium malate and complex calcium salt of citric acid and malic acid is mixed with the solid solution of formula (1) or the mixture of claim 2 The animal mineral supplement according to claim 1 or 2 . 下記式(1)
Figure 0004942307
(但し、式中、M はCr 3+ ,Co 2+ ,Ni 2+ の少なくとも1種以上を示し、x ,x 2 ,x 3 ,x 4 ,x,yおよびzは次の条件を満足する、x +x 2 +x 3 +x 4 =x,0<x <0.1,0<x 2 <0.2,0<x 3 <0.02,0<x 4 <0.04,0<x<0.15,0≦y≦0.004,0≦z<0.05)で表される水酸化マグネシウム系固溶体と、亜セレン酸ナトリウム、セレン酵母、ヨウ化カリウム、ヨウ化ナトリウム、モリブデン酸ナトリウム、モリブデン酸アンモニウムからなる群から選択されたセレン、ヨウ素およびモリブデン含有化合物の1種以上を水媒体中で混合した後、スプレードライまたは凍結乾燥することを特徴とする動物用ミネラル補給剤の製造方法。
Following formula (1)
Figure 0004942307
(In the formula, M 1 represents at least one of Cr 3+ , Co 2+ and Ni 2+ , and x 1 , x 2 , x 3 , x 4 , x, y and z satisfy the following conditions: x 1 + x 2 + x 3 + x 4 = x, 0 <x 1 <0.1,0 <x 2 <0.2,0 <x 3 <0.02,0 <x 4 <0.04,0 <x <0.15, 0 ≦ y ≦ 0.004, 0 ≦ z <0.05), magnesium hydroxide solid solution, sodium selenite, selenium yeast, potassium iodide, sodium iodide, molybdic acid Production of a mineral supplement for animals, wherein one or more of selenium, iodine and molybdenum-containing compounds selected from the group consisting of sodium and ammonium molybdate are mixed in an aqueous medium and then spray-dried or freeze-dried Method.
JP2005112150A 2005-04-08 2005-04-08 Animal mineral supplements Expired - Fee Related JP4942307B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005112150A JP4942307B2 (en) 2005-04-08 2005-04-08 Animal mineral supplements

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005112150A JP4942307B2 (en) 2005-04-08 2005-04-08 Animal mineral supplements

Publications (2)

Publication Number Publication Date
JP2006290780A JP2006290780A (en) 2006-10-26
JP4942307B2 true JP4942307B2 (en) 2012-05-30

Family

ID=37411740

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005112150A Expired - Fee Related JP4942307B2 (en) 2005-04-08 2005-04-08 Animal mineral supplements

Country Status (1)

Country Link
JP (1) JP4942307B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010001276A (en) * 2008-06-18 2010-01-07 Ada Bio株式会社 Molybdenum-containing hair-restoration and hair-growth agent, gray-hair inhibitor, external preparation for skin and differentiation inducing agent
JP7392976B2 (en) * 2019-11-22 2023-12-06 株式会社海水化学研究所 mineral supplement

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57156419A (en) * 1981-03-24 1982-09-27 Kyowa Chem Ind Co Ltd Remedy for sideropenia
JPS606619A (en) * 1983-06-27 1985-01-14 Kyowa Chem Ind Co Ltd Remedy for hypoferremia and its preparation
JP2003267810A (en) * 2002-03-13 2003-09-25 Kaisui Kagaku Kenkyusho:Kk Disinfecting and mineral-replenishing agent for agriculture and method for producing the same
JP5113315B2 (en) * 2003-09-17 2013-01-09 株式会社海水化学研究所 Agricultural crop mineral supplement and method for producing the same

Also Published As

Publication number Publication date
JP2006290780A (en) 2006-10-26

Similar Documents

Publication Publication Date Title
US6197815B1 (en) Amino acid chelates to reduce still births and increase birth weight in non-human animals
JPS5942683B2 (en) Essential metal ion complex
US4103003A (en) Composition for improving biologic development
JPH06227992A (en) Preparation composition suitable for reticuloendothelial system agent and remedy of pancreas fibrosis and chronic pain and its preparation and application
WO2010034160A1 (en) Preparation and use of selenium-coated basic copper chloride
JPH02184689A (en) Copper complex salt and use thereof
Chauhan et al. Chitosan-thiomer stabilized silver nano-composites for antimicrobial and antioxidant applications
JP4942307B2 (en) Animal mineral supplements
JP2805254B2 (en) Aqueous food supplement for livestock and method for producing the same
DK2125847T3 (en) The ligand-modified poly oxo-hydroxy-metalionmaterialer, uses thereof and methods of preparation thereof
JPH0717803A (en) Antimicrobial calcium carbonate powder
JPH08291190A (en) New process for producing picolinic acid/chromium conjugate
JP3484689B2 (en) Trace element preparation
CN110938009A (en) Preparation method of amino acid chelated ferrous iron and iron supplement preparation thereof
CN106243176A (en) The copper complex formazan preparation method of sucrose
US6517862B2 (en) Acesulfame-metal complexes, process for their preparation and their use
JP6227762B2 (en) Use of ethylenediamine metal complexes to deliver superabsorbent metals for animal nutrition
JP7392976B2 (en) mineral supplement
JPH0853358A (en) Calcium composition excellent in absorbability
KR20050083679A (en) Use of metal chelates in human or animal feeding
CN110002489A (en) A kind of preparation method of superfine powder state basic copper chloride
CN102349643A (en) Salt
CN102038084A (en) Premix containing iron sucrose for raising pigs
JP5113315B2 (en) Agricultural crop mineral supplement and method for producing the same
KR880002033B1 (en) Process for producing zn-fe-cu-methionine ligand complex

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080402

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20080402

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20110601

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20110602

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110907

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111107

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111124

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120116

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120210

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120228

R150 Certificate of patent or registration of utility model

Ref document number: 4942307

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150309

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150309

Year of fee payment: 3

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150309

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150309

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees